Valeant Pharmaceuticals International (VRX)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
20-Oct-10 5:49 PM
View: 
Chaudhuri Bhaskar
President
Valeant Pharmaceuticals Int... (VRX) 28-Sep-10Disposition 333,438----(100%)
333.44K to 0
30-Sep-10 8:53 PM
View: 
Valueact Holdings, L.P.
10% Owner
Valeant Pharmaceuticals Int... (VRX) 28-Sep-10Disposition 15,163,000----(100%)
15.16M to 0
30-Sep-10 8:35 PM
View: 
Melas Kyriazi Theo
Director
Valeant Pharmaceuticals Int... (VRX) 28-Sep-10Disposition 60,627----(100%)
60.63K to 0
20-Oct-10 5:55 PM
View: 
Pearson J. Michael
CEO and Chairman
Valeant Pharmaceuticals Int... (VRX) 28-Sep-10Disposition 1,931,500----(100%)
1.93M to 0
20-Oct-10 5:59 PM
View: 
Blott Peter J
EVP, Chief Financial Officer
Valeant Pharmaceuticals Int... (VRX) 28-Sep-10Disposition 216,889----(100%)
216.89K to 0
06-Jul-10 7:48 PM
View: 
Melas Kyriazi Theo
Director
Valeant Pharmaceuticals Int... (VRX) 01-Jul-10Grant 369----< 1%
47.28K to 47.65K
13-May-10 2:44 PM
View: 
Valueact Holdings, L.P.
10% Owner
Valeant Pharmaceuticals Int... (VRX) 11-May-10Grant
Duplicate
2,677----< 1%
15.16M to 15.16M
13-May-10 1:04 PM
View: 
Melas Kyriazi Theo
Director
Valeant Pharmaceuticals Int... (VRX) 11-May-10Grant 2,677----6%
44.6K to 47.28K
13-May-10 2:27 PM
View: 
Morfit G Mason
Director
Valeant Pharmaceuticals Int... (VRX) 11-May-10Grant 2,677----12%
22.01K to 24.69K
04-May-10 2:37 PM
View: 
Valueact Holdings, L.P.
10% Owner
Valeant Pharmaceuticals Int... (VRX) 30-Apr-10Market Sale 2,637,540$40.41$106,583,000.00(15%)
17.78M to 15.14M
(17%)
05-Apr-10 7:12 PM
View: 
Melas Kyriazi Theo
Director
Valeant Pharmaceuticals Int... (VRX) 01-Apr-10Grant 434----< 1%
44.17K to 44.6K
18-Mar-10 7:20 PM
View: 
Blott Peter J
EVP & CFO
Valeant Pharmaceuticals Int... (VRX) 16-Mar-10Payment of Exercise 436$39.86$17,379.00(< 1%)
90.92K to 90.49K
(1%)
03-Feb-10 3:18 PM
View: 
Pearson J. Michael
CEO and Chairman of the Board
Director
Valeant Pharmaceuticals Int... (VRX) 01-Feb-10Payment of Exercise 31,840$33.72$1,073,640.00(3%)
1.04M to 1.0M
(3%)
05-Jan-10 5:57 PM
View: 
Melas Kyriazi Theo
Director
Valeant Pharmaceuticals Int... (VRX) 04-Jan-10Grant 591----1%
43.58K to 44.17K
17-Dec-09 7:31 PM
View: 
Blott Peter J
EVP & CFO
Valeant Pharmaceuticals Int... (VRX) 16-Dec-09Payment of Exercise 375$31.78$11,917.50(< 1%)
91.3K to 90.92K
0%
11-Dec-09 3:32 PM
View: 
Chaudhuri Bhaskar
President
Valeant Pharmaceuticals Int... (VRX) 10-Dec-09Grant 6,910----6%
110.39K to 117.3K
08-Dec-09 7:16 PM
View: 
Pearson J. Michael
CEO and Chairman of the Board
Director
Valeant Pharmaceuticals Int... (VRX) 07-Dec-09Payment of Exercise 188,875$31.93$6,030,780.00(15%)
1.22M to 1.04M
0%
23-Nov-09 6:36 PM
View: 
Chaudhuri Bhaskar
President
Valeant Pharmaceuticals Int... (VRX) 20-Nov-09Market Purchase 3,000$33.31$99,928.203%
104.01K to 107.01K
(< 1%)
19-Nov-09 1:50 PM
View: 
Chaudhuri Bhaskar
President
Valeant Pharmaceuticals Int... (VRX) 18-Nov-09Market Purchase 2,385$33.58$80,097.102%
101.63K to 104.01K
2%
12-Nov-09 3:39 PM
View: 
Chaudhuri Bhaskar
President
Valeant Pharmaceuticals Int... (VRX) 10-Nov-09Market Purchase 1,525$32.81$50,039.202%
100.1K to 101.63K
2%
05-Oct-09 6:25 PM
View: 
Melas Kyriazi Theo
Director
Valeant Pharmaceuticals Int... (VRX) 01-Oct-09Grant 346----< 1%
43.23K to 43.58K
14-Sep-09 2:57 PM
View: 
Chaudhuri Bhaskar
President
Valeant Pharmaceuticals Int... (VRX) 10-Sep-09Grant 3,373----3%
100.1K to 103.47K
11-Dec-09 3:32 PM
View: 
Chaudhuri Bhaskar
President
Valeant Pharmaceuticals Int... (VRX) 10-Sep-09Grant
Duplicate
3,373----3%
107.01K to 110.39K
17-Aug-09 3:05 PM
View: 
Chaudhuri Bhaskar
President
Valeant Pharmaceuticals Int... (VRX) 14-Aug-09Market Purchase 3,373$26.69$90,026.403%
96.73K to 100.1K
< 1%
28-Jul-09 5:05 PM
View: 
Valueact Holdings, L.P.
10% Owner
Valeant Pharmaceuticals Int... (VRX) 28-Jul-09Market Purchase 300$24.97$7,491.00< 1%
17.78M to 17.78M
1%
28-Jul-09 5:05 PM
View: 
Valueact Holdings, L.P.
10% Owner
Valeant Pharmaceuticals Int... (VRX) 27-Jul-09Market Purchase 25,000$24.91$622,750.00< 1%
17.75M to 17.78M
< 1%
28-Jul-09 5:05 PM
View: 
Valueact Holdings, L.P.
10% Owner
Valeant Pharmaceuticals Int... (VRX) 24-Jul-09Market Purchase 14,100$24.88$350,808.00< 1%
17.74M to 17.75M
< 1%
23-Jul-09 4:45 PM
View: 
Valueact Holdings, L.P.
10% Owner
Valeant Pharmaceuticals Int... (VRX) 23-Jul-09Market Purchase 25,000$24.75$618,750.00< 1%
17.71M to 17.74M
1%
27-Jul-09 7:40 PM
View: 
Pearson J. Michael
CEO and Chairman of the Board
Director
Valeant Pharmaceuticals Int... (VRX) 23-Jul-09Payment of Exercise 34,803$24.73$860,678.00(3%)
1.26M to 1.22M
(2%)
23-Jul-09 4:45 PM
View: 
Valueact Holdings, L.P.
10% Owner
Valeant Pharmaceuticals Int... (VRX) 22-Jul-09Market Purchase 25,000$24.36$609,000.00< 1%
17.69M to 17.71M
3%
23-Jul-09 4:45 PM
View: 
Valueact Holdings, L.P.
10% Owner
Valeant Pharmaceuticals Int... (VRX) 21-Jul-09Market Purchase 50,000$23.76$1,188,000.00< 1%
17.64M to 17.69M
6%
20-Jul-09 5:27 PM
View: 
Valueact Holdings, L.P.
10% Owner
Valeant Pharmaceuticals Int... (VRX) 20-Jul-09Market Purchase 50,000$23.60$1,180,000.00< 1%
17.59M to 17.64M
6%
20-Jul-09 5:27 PM
View: 
Valueact Holdings, L.P.
10% Owner
Valeant Pharmaceuticals Int... (VRX) 17-Jul-09Market Purchase 50,000$23.78$1,189,000.00< 1%
17.54M to 17.59M
6%
20-Jul-09 5:27 PM
View: 
Valueact Holdings, L.P.
10% Owner
Valeant Pharmaceuticals Int... (VRX) 16-Jul-09Market Purchase 50,000$23.53$1,176,500.00< 1%
17.49M to 17.54M
7%
15-Jul-09 5:47 PM
View: 
Valueact Holdings, L.P.
10% Owner
Valeant Pharmaceuticals Int... (VRX) 15-Jul-09Market Purchase 50,000$23.59$1,179,500.00< 1%
17.44M to 17.49M
6%
15-Jul-09 5:47 PM
View: 
Valueact Holdings, L.P.
10% Owner
Valeant Pharmaceuticals Int... (VRX) 14-Jul-09Market Purchase 50,000$23.34$1,167,000.00< 1%
17.39M to 17.44M
8%
15-Jul-09 5:47 PM
View: 
Valueact Holdings, L.P.
10% Owner
Valeant Pharmaceuticals Int... (VRX) 13-Jul-09Market Purchase 50,000$22.94$1,147,000.00< 1%
17.34M to 17.39M
9%
10-Jul-09 6:03 PM
View: 
Valueact Holdings, L.P.
10% Owner
Valeant Pharmaceuticals Int... (VRX) 10-Jul-09Market Purchase 100,000$22.78$2,278,000.00< 1%
17.24M to 17.34M
10%
10-Jul-09 6:03 PM
View: 
Valueact Holdings, L.P.
10% Owner
Valeant Pharmaceuticals Int... (VRX) 09-Jul-09Market Purchase 100,000$22.92$2,292,000.00< 1%
17.14M to 17.24M
10%
10-Jul-09 6:03 PM
View: 
Valueact Holdings, L.P.
10% Owner
Valeant Pharmaceuticals Int... (VRX) 08-Jul-09Market Purchase 50,000$23.69$1,184,500.00< 1%
17.09M to 17.14M
6%
07-Jul-09 5:35 PM
View: 
Valueact Holdings, L.P.
10% Owner
Valeant Pharmaceuticals Int... (VRX) 07-Jul-09Market Purchase 50,000$24.16$1,208,000.00< 1%
17.04M to 17.09M
4%
07-Jul-09 5:35 PM
View: 
Valueact Holdings, L.P.
10% Owner
Valeant Pharmaceuticals Int... (VRX) 06-Jul-09Market Purchase 5,110$24.95$127,494.00< 1%
17.03M to 17.04M
< 1%
07-Jul-09 5:35 PM
View: 
Valueact Holdings, L.P.
10% Owner
Valeant Pharmaceuticals Int... (VRX) 02-Jul-09Market Purchase 2,400$24.99$59,976.00< 1%
17.03M to 17.03M
< 1%
01-Jul-09 8:23 PM
View: 
Melas Kyriazi Theo
Director
Valeant Pharmaceuticals Int... (VRX) 01-Jul-09Grant 363----< 1%
42.87K to 43.23K
01-Jul-09 5:41 PM
View: 
Valueact Holdings, L.P.
10% Owner
Valeant Pharmaceuticals Int... (VRX) 29-Jun-09Market Purchase 900$24.99$22,491.00< 1%
17.03M to 17.03M
< 1%
26-Jun-09 5:07 PM
View: 
Valueact Holdings, L.P.
10% Owner
Valeant Pharmaceuticals Int... (VRX) 26-Jun-09Market Purchase 25,000$24.93$623,250.00< 1%
17.0M to 17.03M
< 1%
26-Jun-09 5:07 PM
View: 
Valueact Holdings, L.P.
10% Owner
Valeant Pharmaceuticals Int... (VRX) 25-Jun-09Market Purchase 1,600$24.59$39,344.00< 1%
17.0M to 17.0M
2%
26-Jun-09 5:07 PM
View: 
Valueact Holdings, L.P.
10% Owner
Valeant Pharmaceuticals Int... (VRX) 24-Jun-09Market Purchase 25,000$24.47$611,750.00< 1%
16.98M to 17.0M
3%
23-Jun-09 4:40 PM
View: 
Valueact Holdings, L.P.
10% Owner
Valeant Pharmaceuticals Int... (VRX) 23-Jun-09Market Purchase 50,000$23.74$1,187,000.00< 1%
16.93M to 16.98M
6%
23-Jun-09 4:40 PM
View: 
Valueact Holdings, L.P.
10% Owner
Valeant Pharmaceuticals Int... (VRX) 22-Jun-09Market Purchase 39,100$23.92$935,272.00< 1%
16.89M to 16.93M
5%